Review Articie
08 April 2026
The Clinical and Operational Value of Early Comprehensive NGS in Non-Small Cell Lung Cancer
Demirhan Yunus Emre
1
yunusedemirhan@gmail.com
,
Yoakam Marcus
2
,
Soltani Adam
3
,
Gill Arshdeep
3
,
Dalia Samir
4
show author's information
- 1 : Mercy East Side Communities, Saint Louis, Missouri, United States of America
- 2 : Kansas City University College of Osteopathic Medicine, Joplin, Missouri, United States of America
- 3 : Alice L. Walton School of Medicine, Bentonville, Arkansas, United States of America
- 4 : Department of Medical Oncology, Mercy Hospital, Joplin, Missouri, United States of America
DOI:
10.55578/amsr.2604.003
Keywords:
non-small cell lung cancer
,
next-generation sequencing
,
comprehensive genomic profiling
,
circulating tumor DNA
,
healthcare economics
,
molecular tumor board
,
artificial intelligence
,
minimal residual disease
